11.	Stock Options and Award Programs

The Company’s stock incentive plan is administered by the Compensation Committee and authorizes the grant or award of incentive stock options, non-qualified stock options, restricted stock awards, stock appreciation rights, dividend equivalent rights, performance unit awards and phantom shares. The Company issues new shares of common stock upon the exercise of stock options. Any shares associated with forfeited awards are added back to the number of shares to be granted under the stock incentive plan. The Company has issued restricted stock awards and non-qualified stock option awards as described below.

Restricted Stock Awards

On November 18, 2010, the Company’s Compensation Committee granted Steve L. Komar and James T. McCubbin each an award of 250,000 shares of restricted stock of the Company, the vesting of which is based upon the earlier to occur of (a) the seventh anniversary date of the grant, or (b) an acceleration event as determined on the date of grant by the Compensation Committee and set forth in the award agreement with respect to such grant. There were no changes in vesting requirements or activity related to restricted stock awards (RSA) during the three month period ended March 31, 2015. At March 31, 2015, the Company had approximately $229,500 of total unamortized RSA compensation expense.

Stock Option Awards

The Company did not grant any stock options during the three month period ended March 31, 2015. Stock option awards reflected in the tables below cover the period from 1999 through March 31, 2015. A summary of stock option and RSA activity as of March 31, 2015, and changes during three month period ended March 31, 2015 is set forth below:

	Restricted Stock				Stock Options
			Weighted				Weighted
			Average				Average
NON-VESTED AWARDS	Shares		Exercise Price		Shares		Exercise Price
	(Unaudited)
Non-vested balances, January 1, 2015		205,952	$	1.22		1,340,838	$	0.57
Cancelled		-		-		(250,000)	$	0.39
Vested		(17,857)	$	1.22		(416,666)	$	0.27
Non-vested balances, March 31, 2015		188,095	$	1.22		674,172	$	0.83

	Restricted Stock				Stock Options
			Weighted				Weighted
			Average				Average
OUTSTANDING AND EXERCISABLE AWARDS	Shares		Exercise Price		Shares		Exercise Price
	(Unaudited)
Awards outstanding, January 1, 2015		294,048	$	1.22		2,791,601	$	0.83
Canceled		-		-		(250,000)	$	0.74
Exercised		-		-		(217,160)	$	0.58
Vested		17,857	$	1.22		-		-
Awards outstanding, March 31, 2015		311,905	$	1.22		2,324,441	$	0.86

Awards vested and expected to vest,
March 31, 2015		311,905	$	1.22		2,324,441	$	0.86

Awards outstanding and exercisable,
March 31, 2015		-		-		1,650,269	$	0.76

A summary of stock option and RSA activity as of March 31, 2014, and changes during three month period ended March 31, 2014 is set forth below:

	Restricted Stock				Stock Options
			Weighted				Weighted
			Average				Average
NON-VESTED AWARDS	Shares		Exercise Price		Shares		Exercise Price
	(Unaudited)
Non-vested balances, January 1, 2004		277,381	$	1.22		1,900,000	$	0.37
Cancelled		-		-		50,000	$	0.59
Vested		(17,857)	$	1.22		(422,912)	$	0.25
Non-vested balances, March 31, 2014		259,524	$	1.22		1,527,088	$	0.41

	Restricted Stock				Stock Options
			Weighted				Weighted
			Average				Average
OUTSTANDING AND EXERCISABLE AWARDS	Shares		Exercise Price		Shares		Exercise Price
	(Unaudited)
Awards outstanding, January 1, 2004		222,619	$	1.22		3,336,500	$	0.72
Granted		-		-		50,000	$	1.48
Vested		17,857	$	1.22		-		-
Awards outstanding, March 31, 2014		240,476	$	1.22		3,386,500	$	0.73

Awards vested and expected to vest,
March 31, 2014		240,476	$	1.22		3,386,500	$	0.73

Awards outstanding and exercisable,
March 31, 2014		-		-		1,859,412	$	0.71

The weighted-average remaining contractual life and the aggregate intrinsic value (the amount by which the fair value of the Company’s stock exceeds the exercise price of the option) of the stock options outstanding, exercisable, and vested and expected to vest as of March 31, 2015 are as follows:

			Vested and		Outstanding
			Expected to		and
	Outstanding		Vest		Exercisable
				(Unaudited)
Weighted-average remaining contractual life (in years)		3.3		3.3		2.7
Aggregate intrinsic value	$	1,115,978	$	1,115,978	$	952,185

Aggregate intrinsic value represents total pretax intrinsic value (the difference between WidePoint’s closing stock price on March 31, 2015 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on March 31, 2015. The intrinsic value will change based on the fair market value of WidePoint’s stock. The total intrinsic value of options exercised were approximately $178,200 during the three months ended March 31, 2015. There were no exercises of options during the three months ended March 31, 2014.

Share-based compensation (including restricted stock awards) represents both stock options based expense and stock grant expense. For the three month periods ended March 31, 2015 and 2014, the Company recognized share-based compensation expense of approximately $37,500 and $82,700, respectively. During the three month period ended March 31, 2015, there were stock options of 250,000 that expired unexercised that were cancelled as a result of employment terminations.

At March 31, 2015, the Company had approximately $336,900 of total unamortized compensation expense, net of estimated forfeitures, related to stock option plans that will be recognized over the weighted average remaining period of 2.0 years.